Pharma Needs Incentives To Optimize Cancer Drugs, EMA Oncology Chair Says

 
• By Eliza Slawther
  
Incentives are needed to encourage companies to focus on dose optimization (Shutterstock)

More from Post-Marketing Regulation & Studies

More from Advanced Technologies